You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 12/26/2014

Company Name Symbol %Change
ONCOLYTICS B ONCY
19.28%
PLANAR SYSTE PLNR
16.19%
AMBARELLA IN AMBA
7.47%
AGENUS INC AGEN
7.27%
CHINA LIFE I LFC
7.02%
Mesa Laboratories Inc. (MLAB) Corporate Event Announcement Notice

Print Share

Nov 09, 2012 (Wall Street Horizon via COMTEX) --

Mesa Laboratories Inc. (MLAB)
Expected next earnings release:
Announcement date: 2/6/2013 - After Market
Earnings Quarter: Q3
Announcement Status: Unconfirmed
Expected next dividend:
Dividend Announcement Date: 11/7/2012
Dividend Record Date: 11/30/2012
Dividend Pay Date: 12/14/2012
Dividend Amount: 0.14

(C) 2012 Wall Street Horizon, Inc.
The Earnings Calendar Company(sm)
All rights reserved
www.WallStreetHorizon.com

**********************************************************************

As of Monday, 11-05-2012 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated a DOWNTREND on
03-16-2012 for MLAB @ $53.49.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2012 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

    Zacks Research is Reported On:

    Zacks Investment Research

    is an A+ Rated BBB

    Accredited Business.